scholarly journals Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

BMC Cancer ◽  
2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Lambros Vamvakas ◽  
Alexios Matikas ◽  
Athanasios Karampeazis ◽  
Dora Hatzidaki ◽  
Stelios Kakolyris ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Elderly Patients ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Research Group ◽  
Phase Ii Study ◽  
Line Treatment ◽  
Oncology Research ◽  
Multicenter Phase ◽  
Vulnerable Elderly

scholarly journals Oral doxifluridine in elderly patients with metastatic colorectal cancer: A multicenter phase II study

1994 ◽  
Vol 5 (8) ◽  
pp. 760-762 ◽  
Author(s):  
A. Falcone ◽  
E. Pfanner ◽  
S. Ricci ◽  
M. Bertuccelli ◽  
C. Cianci ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Elderly Patients ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Multicenter Phase
Sign in / Sign up

Export Citation Format

Share Document